Search clinical trials for: Bortezomib, cyclophosphamide, thalidomide, dexamethasone
Total 774 results
-
Massachusetts General HospitalCompletedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed Follicular LymphomaUnited States, Puerto Rico
-
St. Luke's Medical CenterUnknown
-
University of BolognaUnknownNon-Hodgkin's Lymphoma | Acute Lymphoblastic LeukemiaItaly
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Terminated
-
M.D. Anderson Cancer CenterWithdrawn
-
Mayo ClinicRecruitingPlasma Cell MyelomaUnited States
-
University Hospital FreiburgMerck Sharp & Dohme LLC; Janssen-Cilag Ltd.Completed
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingMultiple Myeloma | Newly Diagnosed Multiple Myeloma | Autologous Stem Cell TransplantationUnited States
-
Jin Lu, MDRecruiting
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, Italy, Japan, Poland, Spain, United Kingdom, France, Germany, Greece, Canada, China, Israel, Korea, Republic of, Brazil, Russian Federation, Czechia, New Zealand, Turkey
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom
-
Alliance Foundation Trials, LLC.Celgene; Janssen, LPWithdrawnRelapsed or Refractory Multiple Myeloma
-
BayerTerminatedMultiple MyelomaKorea, Republic of, Spain, United States
-
PfizerCompletedMultiple MyelomaUnited States, Germany, Czech Republic
-
University of Wisconsin, MadisonCompletedMantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States, Saudi Arabia, Puerto Rico
-
PETHEMA FoundationBristol-Myers Squibb; Sanofi; Adknoma; Start from scratchNot yet recruitingNewly Diagnosed Multiple MyelomaSpain
-
GlaxoSmithKlineIqvia Pty LtdActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Novartis PharmaceuticalsCompletedMultiple MyelomaChina, United States, Italy, Taiwan, Egypt, Japan, Turkey, Germany, Netherlands, Canada, Australia, Austria, Israel, Sweden, United Kingdom, Korea, Republic of, Spain, Hong Kong, Thailand, France, Belgium, Norway, South Africa, Brazil, ... and more
-
Memorial Sloan Kettering Cancer CenterRecruitingSickle Cell Disease | Thalassemia | Thalassemia, BetaUnited States
-
Tanja Andrea GruberRecruitingAcute Lymphoblastic Leukemia, Pediatric | Refractory Acute Lymphoblastic Leukemia | Relapsed Acute Lymphoblastic LeukemiaUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada, Australia, China, Germany, Belgium, Malaysia, Turkey, Japan, Israel, Sweden, Spain, United Kingdom, Czechia, Denmark, Brazil, Italy, France, Netherlands, Poland, Austria, Portugal, Greece, India
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Belgium, Korea, Republic of, United Kingdom, Sweden, Italy, Denmark, Japan, Taiwan, China, Germany, Spain, France, Netherlands, Turkey, Russian Federation, Poland, Greece, Argentina, Brazil
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCActive, not recruiting
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States, Canada
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CephalonCompleted
-
Bristol-Myers SquibbTerminatedMultiple MyelomaUnited States, Italy, France, Spain
-
Bristol-Myers SquibbExelixisCompletedAdvanced Cancer, Various, NOSUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University of ArkansasNational Institutes of Health (NIH); Ortho Biotech Clinical Affairs, L.L.C.Completed
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneCompletedMultiple MyelomaUnited States
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaAustria, Greece, Italy, Netherlands, Germany
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
University of Heidelberg Medical CenterActive, not recruiting
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgenCompletedMultiple MyelomaAustria, Germany
-
University of ArkansasCompleted
-
Fudan UniversityUnknown
-
RenJi HospitalThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsRecruiting
-
GlaxoSmithKlineActive, not recruiting
-
University of Heidelberg Medical CenterCompleted
-
Nantes University HospitalJanssen PharmaceuticaNot yet recruiting
-
AbbVieNot yet recruiting
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Netherlands, Belgium, Korea, Republic of, United Kingdom, Sweden, Denmark, Italy, Japan, Germany, France, Spain, Australia, Israel, Poland, Greece
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, Germany, Netherlands, Israel, Spain, Saudi Arabia, France
-
Cancer Trials IrelandCompleted
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
University of Maryland, BaltimoreCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States